Publications

Dias-Santagata D, Heist RS, Bard AZ, da Silva AFL, Dagogo-Jack I, Nardi V, Ritterhouse LL, Spring LM, Jessop N, Farahani AA, Mino-Kenudson M, Allen J, Goyal L, Parikh A, Misdraji J, Shankar G, Jordan JT, Martinez-Lage M, Frosch M, Graubert T, Fathi AT, Hobbs GS, Hasserjian RP, Raje N, Abramson J, Schwartz JH, Sullivan RJ, David Michael Miller, Hoang MP, Isakoff S, Ly A, Bouberhan S, Watkins J, Oliva E, Wirth L, Sadow PM, Faquin W, Cote GM, Hung YP, Gao X, Wu CL, Garg S,, Rivera M, Le LP, John Iafrate A, Juric D,, Hochberg EP, Clark J, Bardia A, Lennerz JK (2022). Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network. Oncologist.

DOI

Gross, Neil D., David Michael Miller, Khushalani, Nikhil I., Divi, Vasu, Ruiz, Emily S., Lipson, Evan J., Meier, Friedegund, Su, Yungpo B., Swiecicki, Paul L., Atlas, Jennifer, Geiger, Jessica L., Hauschild, Axel, Choe, Jennifer H., Hughes, Brett G.M., Schadendorf, Dirk, Patel, Vishal A., Homsi, Jade, Taube, Janis M., Lim, Annette M., Ferrarotto, Renata, Kaufman, Howard L., Seebach, Frank, Lowy, Israel, Yoo, Suk-Young and Mathias, Melissa and Fenech, Keilah and Han, Hyunsil and Fury, Matthew G. and, Rischin, Danny (2022). Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. New England Journal of Medicine.

Source Document DOI

Silk, Ann W, Barker, Christopher A, Bhatia, Shailender, Bollin, Kathryn B, Chandra, Sunandana, Eroglu, Zeynep, Gastman, Brian R, Kendra, Kari L, Kluger, Harriet, Lipson, Evan J, Madden, Kathleen, David Michael Miller, Nghiem, Paul, Pavlick, Anna C, Puzanov, Igor, Rabinowits, Guilherme, Ruiz, Emily S, Sondak, Vernon K, Tavss, Edward A, Tetzlaff, Michael T, Brownell, Isaac (2022). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. Journal for ImmunoTherapy of Cancer.

PDF Source Document DOI

Sophia Shalhout, Kevin S Emerick, Howard L Kaufman, Ann W Silk, Manisha Thakuria, David Michael Miller (2022). A Retrospective Study of Ipilimumab Plus Nivolumab in Anti-PD-L1/PD-1 Refractory Merkel Cell Carcinoma. Journal for Immunotherapy.

Source Document DOI

David Michael Miller, Sophia Shalhout (2022). StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries. Preprint.

Code Project Project Video

Sophia Shalhout, Farees Saqlain, Kayla Wright, Oladayo Akinyemi, David Michael Miller (2021). Generalizable EHR-R-REDCap Pipeline for a National Multi-Institutional Rare Tumor Patient Registry. Preprint.

Project Project DOI

David Michael Miller, Sophia Shalhout (2021). BodyMapR - An R Package and Shiny Application Designed to Generate Anatomical Visualizations of Cancer Lesions. JAMIA Open.

Code Project Source Document DOI

David Michael Miller, Sophia Shalhout, Denise Casey, Lola Fashoyin-Aje, Steven Lemery, Marc Theoret, Richard Pazdur (2021). Impact of an Evolving Regulatory Landscape on Skin Cancer Drug Development in the U.S. Preprint.

Project

Michael Wu, Katherine L Reinshagen, Mary Beth Cunnane, Sophia Shalhout, Howard Kaufman, David Michael Miller, Kevin S Emerick (2021). Assessing Changes in Clinical Perineural Invasion during Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma. Laryngoscope.

DOI

David Michael Miller, Sophia Shalhout, Farees Saqlain, Vishal A. Patel, Kenneth Y. Tsai, Ravikumar Komandur, Bill Louv, Michael K. Wong (2021). The Merkel Cell Carcinoma Patient Registry-From Promise to Prototype to Patient. Preprint.

Project Project

Farees Saqlain, Sophia Shalhout, Kevin S. Emerick, Howard L. Kaufman, Yen-Lin E. Chen, James C. Cusack, Kayla Wright, David Michael Miller (2021). Diagnostic yield of staging brain magnetic resonance imaging is low in Merkel cell carcinoma - A single-institution cohort study.

PDF Project Project Source Document DOI

David Michael Miller, Sophia Shalhout (2021). GENETEX - A GENomics Report TEXt Mining R Package and Shiny Application Designed to Capture Real-World Clinico-Genomic Data.

PDF Code Dataset Project Project Video Source Document

Sophia Shalhout, Kevin S. Emerick, Howard L. Kaufman, David Michael Miller (2021). Clinical Utility of Cell-free DNA Liquid Biopsies in Merkel Cell Carcinoma.

Project Project

Sophia Shalhout, Kevin S. Emerick, Howard L. Kaufman, David Michael Miller (2021). Immunotherapy for Non-Melanoma Skin Cancer.

PDF Project Project Source Document DOI

Farees Saqlain, Sophia Shalhout, David Michael Miller (2021). Evaluation of clinical characteristics and pre-biopsy impressions of primary Merkel cell carcinoma of the skin. Dermatology Online Journal.

Project Project

Sophia Shalhout, Howard L. Kaufman, Ryan J. Sullivan, Donald Lawrence, David Michael Miller (2021). Immune Checkpoint Inhibition in Marjolin Ulcer - A Case Series.

Project Source Document DOI

David Michael Miller, Kevin Emerick (2021). Commentary on Surgical Margins in MCC.

Source Document

Farees Saqlain, Sophia Shalhout, Kayla Wright, David Michael Miller (2021). Microsatellitosis in Merkel cell carcinoma - a staging quandary.

Project Source Document

Sophia Shalhout, John Chul Park, Kevin S. Emerick, Ryan J. Sullivan, Howard L. Kaufman, David Michael Miller (2021). Real-world assessment of response to anti-PD1 therapy in advanced cutaneous squamous cell carcinoma.

PDF Project Source Document DOI

FareesSaqlain, Sophia Shalhout, Keith T. Flaherty, Kevin S. Emerick, David Michael Miller (2020). A REDCap-Based Operational Tool to Guide Care Coordination in a Multidisciplinary Cutaneous Oncology Clinic.

Source Document DOI

Nicholas Macedo, David Michael Miller, Rizwan Haq, Howard L Kaufman (2020). Clinical landscape of oncolytic virus research in 2020.

Project Source Document DOI

Farees Saqlain, Sophia Shalhout, Kevin S. Emerick, Thomas G. Neilan, Tatyana Sharova, David Michael Miller (2020). Metastatic Merkel Cell Carcinoma Masquerading as multiple immune-related Adverse Events.

PDF Project Source Document DOI

Sophia Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David Michael Miller (2020). Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis.

PDF Project Source Document DOI

Mai P Hoang, Piotr Donizy, Cheng-Lin Wu, Janusz Kopczynski, Malgorzata Pieniazek, David Michael Miller, Janusz Ryś (2020). TdT Expression Is a Marker of Better Survival in Merkel Cell Carcinoma, and Expression of B-Cell Markers Is Associated With Merkel Cell Polyomavirus.

DOI

Sophia Shalhout, Romi Bloom, Lynn Drake, David Michael Miller (2020). Evaluation of the fragility of pivotal trials used to support FDA approval for plaque psoriasis. Journal of the American Academy of Dermatology.

Project Source Document DOI

Sophia Shalhout, Myrna R. Nahas, Reed E. Drews, David Michael Miller (2020). Generalized Acquired Cutis Laxa Associated with Monoclonal Gammopathy of Dermatological Significance.

Source Document

Melms, J. C., Vallabhaneni, S., Mills, C. E., Yapp, C., Chen, J. Y., Morelli, E., Waszyk, P., Kumar, S., Deming, D., Moret, N., Rodriguez, S., Subramanian, K., Rogava, M., Cartwright, A. N. R., Luoma, A., Mei, S., Brinker, T. J., David Michael Miller, Spektor, A., Schadendorf, D., Riggi, N., Wucherpfennig, K. W., Sorger, P. K., Izar, B., David Michael Miller (2019). Inhibition of Haspin kinase promotes cell-intrinsic and extrinsic anti-tumor activity.

Source Document

Klebanov, Nikolai, Gunasekera, Nicole S, Lin, William M, Hawryluk, Elena B, David Michael Miller, Reddy, Bobby Y, Christman, Mitalee P, Beaulieu, Derek, Rajadurai, Suvithan, Duncan, Lyn M, Sober, Arthur J, Tsao, Hensin (2019). Clinical spectrum of cutaneous melanoma morphology..

Source Document

David Michael Miller, Trowbridge, R. M., Desai, A., Drews, R. E. (2018). Eczema Tvecium.

Source Document Follow

Eliades, P., Abraham, B. J., Ji, Z., David Michael Miller, Christensen, C. L., Kwiatkowski, N., Kumar, R., Njauw, C. N., Taylor, M., Miao, B., Zhang, T., Wong, K. K., Gray, N. S., Young, R. A., Tsao, H. (2018). Role of CDK7 in Melanoma.

Source Document Follow

David Michael Miller, Faulkner-Jones, B. E., Stone, J. R., Drews, R. E. (2017). A Complete Response in cSCC with Ipi/Nivo.

Source Document Follow

Bobby Reddy, David Michael Miller, Hensin Tsao (2017). Somatic Driver Mutations in Melanoma.

Source Document

David Michael Miller (2016). A novel multi-CDK inhibitor in Melanoma.

Source Document

David Michael Miller (2016). Molecularly Targeted Therapies and Immunotherapies For Melanoma.

Source Document

David Michael Miller (2016). CDKs as Therapeutic Targets in Melanoma.

Source Document

David Michael Miller (2016). Molecular testing in melanoma.

Source Document

David Michael Miller (2010). Parameters for Establishing Humanized Mouse Models.

Source Document

David Michael Miller (2008). TLR Activation Abrogates Mixed Chimerism.

Source Document

David Michael Miller (2008). Viral infection - a potent barrier to transplantation tolerance.

Source Document

David Michael Miller (2008). TLR Agonists Abrogate Immunological Tolerance.

Source Document

David Michael Miller (2008). Role of Innate Immunity in Transplantation Tolerance.

Source Document

David Michael Miller (2007). Different mechanisms control peripheral and central tolerance.

Source Document

David Michael Miller (2004). Jellypin - a lower eukaryotic serine proteinase inhibitor (serpin).

Source Document

David Michael Miller (2002). The Serpin SQN-5.

Source Document